Category: Pharma News
According to an NIH study, immunotherapy significantly improves the survival rate for persons with lymphomatoid granulomatosis.
According to the findings of a clinical experiment done by scientists at the National Institutes of Health (NIH),…
Pharmacists from CGHS propose significant modifications to the Pharmacy Act including a B Pharm requirement for registration.
The Central Government Health Services (CGHS) chemists have provided some comprehensive suggestions to the expert panel for their…
Experts want Dr. B Suresh to be considered for the position of co-chairman of the expert panel established to reform the Pharmacy Act.
Veteran academic and professional pharmacy experts say the Union government should take into consideration the name of former…
For disposable insulin glargine 100 IU/ml pens, the NPPA establishes a specific price ceiling.
After taking into account the arguments made by Sanofi India Ltd, the Organization of Pharmaceutical Producers of India…
For further investigation, CDSCO requests information on 16 FDCs that Prof. Kokate’s committee identified as being illogical.
All makers of the 16 fixed dose combinations (FDCs) that were previously deemed to be illogical in a…
Pilot testing by NITI Aayog and TBCT of the blood transfusion infrastructure in Uttar Pradesh shows 37% better performance.
According to a pilot study conducted by NITI Aayog and Terumo Blood and Cell Technologies (TBCT), the public-private…
ORDI calls on the government to simplify the documentation process for imported medications exempt from customs duties.
The Organisation of Rare Diseases of India (ORDI) now argues that the Union government would need to simplify…
Under the updated Schedule I of the DPCO, 2013, the NPPA sets ceiling prices for more than 160 scheduled formulations.
In line with its efforts to revise the ceiling price of formulations under the revised Schedule I of…
For Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg, Glenmark Pharmaceuticals receives ANDA approval.
Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg, the generic version of Compazine®1 Tablets, 5 mg and…
Hutchmed has finished rolling-in its NDA for the treatment of refractory metastatic colorectal cancer to the US FDA.
Hutchmed (China) Limited reports that it has finished the rolling submission of a New Drug Application (NDA) to…
